Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958711 · ClinicalTrials.gov registry record · NA
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
A NA study, sponsored by Baxter Healthcare Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00958711 is a NA study that was terminated before completion, run by Baxter Healthcare Corporation. The registered enrollment target is 90 participants.
The verdict
NCT00958711, a NA study, was terminated before completion, sponsored by Baxter Healthcare Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the mechanism of action of the Unite Biomatrix and compare its performance with the standard of care, saline moistened gauze, for the treatment of diabetic foot ulcers.
Interventions
- DEVICE Unite Biomatrix
- OTHER Saline and Gauze
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2009-01 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00958711
The ClinicalTrials.gov registry entry for NCT00958711 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Unite Biomatrix is the first listed.
NCT00958711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00958711 about?
NCT00958711 is a clinical study titled "The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer". The purpose of this study is to assess the mechanism of action of the Unite Biomatrix and compare its performance with the standard of care, saline moistened gauze, for the treatment of diabetic foot ulcers.
What is the current status of trial NCT00958711?
This trial is currently terminated. It is a NA study. The enrollment target is 90 participants. The study started on 2009-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00958711?
The interventions under investigation include: Unite Biomatrix (DEVICE), Saline and Gauze (OTHER).
Who is sponsoring clinical trial NCT00958711?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.